View in EDS

Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.

Saved in:
Bibliographic Details
Title: Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.
Authors: Wang X; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Shinjo K; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan. kshinjo@med.nagoya-u.ac.jp., Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Maruyama R; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Mii S; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Shiraki Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Nishimura T; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Murofushi Y; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Suzuki M; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Kabasawa T; Department of Pathology, Yamagata University, Yamagata, Japan., Futakuchi M; Department of Pathology, Yamagata University, Yamagata, Japan., Kanai A; Life Science Data Research Center, Graduate School of Frontier Sciences, the University of Tokyo, Chiba, Japan., Suzuki Y; Life Science Data Research Center, Graduate School of Frontier Sciences, the University of Tokyo, Chiba, Japan., Enomoto A; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, Japan., Kondo Y; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan. ykondo@med.nagoya-u.ac.jp.; Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, Japan. ykondo@med.nagoya-u.ac.jp.; Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan. ykondo@med.nagoya-u.ac.jp.
Source: British journal of cancer [Br J Cancer] 2026 Feb; Vol. 134 (4), pp. 577-588. Date of Electronic Publication: 2025 Dec 16.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41402556
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Shinjo+K%22">Shinjo K</searchLink>; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan. kshinjo@med.nagoya-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Kumegawa+K%22">Kumegawa K</searchLink>; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Maruyama+R%22">Maruyama R</searchLink>; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Mii+S%22">Mii S</searchLink>; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Shiraki+Y%22">Shiraki Y</searchLink>; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Nishimura+T%22">Nishimura T</searchLink>; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Murofushi+Y%22">Murofushi Y</searchLink>; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+M%22">Suzuki M</searchLink>; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Kabasawa+T%22">Kabasawa T</searchLink>; Department of Pathology, Yamagata University, Yamagata, Japan.<br /><searchLink fieldCode="AU" term="%22Futakuchi+M%22">Futakuchi M</searchLink>; Department of Pathology, Yamagata University, Yamagata, Japan.<br /><searchLink fieldCode="AU" term="%22Kanai+A%22">Kanai A</searchLink>; Life Science Data Research Center, Graduate School of Frontier Sciences, the University of Tokyo, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+Y%22">Suzuki Y</searchLink>; Life Science Data Research Center, Graduate School of Frontier Sciences, the University of Tokyo, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Enomoto+A%22">Enomoto A</searchLink>; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Kondo+Y%22">Kondo Y</searchLink>; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan. ykondo@med.nagoya-u.ac.jp.; Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, Japan. ykondo@med.nagoya-u.ac.jp.; Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan. ykondo@med.nagoya-u.ac.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2026 Feb; Vol. 134 (4), pp. 577-588. <i>Date of Electronic Publication: </i>2025 Dec 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41402556
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-025-03299-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 577
    Titles:
      – TitleFull: Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Shinjo K
      – PersonEntity:
          Name:
            NameFull: Kumegawa K
      – PersonEntity:
          Name:
            NameFull: Maruyama R
      – PersonEntity:
          Name:
            NameFull: Mii S
      – PersonEntity:
          Name:
            NameFull: Shiraki Y
      – PersonEntity:
          Name:
            NameFull: Nishimura T
      – PersonEntity:
          Name:
            NameFull: Murofushi Y
      – PersonEntity:
          Name:
            NameFull: Suzuki M
      – PersonEntity:
          Name:
            NameFull: Kabasawa T
      – PersonEntity:
          Name:
            NameFull: Futakuchi M
      – PersonEntity:
          Name:
            NameFull: Kanai A
      – PersonEntity:
          Name:
            NameFull: Suzuki Y
      – PersonEntity:
          Name:
            NameFull: Enomoto A
      – PersonEntity:
          Name:
            NameFull: Kondo Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2026 Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 134
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1